Edition:
United States

Leap Therapeutics Inc (LPTX.OQ)

LPTX.OQ on NASDAQ Stock Exchange Global Market

6.70USD
18 Sep 2018
Change (% chg)

-- (--)
Prev Close
$6.70
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
8,378
52-wk High
$10.25
52-wk Low
$4.94

Chart for

About

Leap Therapeutics, Inc., formerly HealthCare Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company. The Company engages in acquiring and developing therapeutics in cancer biology. Its lead product candidates for use in clinical trials include TRX518 and DKN-01. DKN-01 is a monoclonal antibody targeting Dickkopf-re... (more)

Overall

Beta: --
Market Cap(Mil.): $98.49
Shares Outstanding(Mil.): 14.70
Dividend: --
Yield (%): --

Financials

  LPTX.OQ Industry Sector
P/E (TTM): -- 103.50 32.14
EPS (TTM): -3.72 -- --
ROI: -182.72 1.52 12.66
ROE: -280.09 0.25 14.84

Earnings vs. Estimates